Canonical ingredient
capecitabine
CAPECITABINE
20 linked products
Official identifiers
CAS 154361-50-9ChEBI CHEBI:31348InChI InChI=1S/C15H22FN3O6/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23)/t8-,10-,11-,13-/m1/s1InChIKey GAGWJHPBXLXJQN-UORFTKCHSA-NKEGG_COMPOUND C12650NHPID_ID 5061SMILES CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F
Names and synonyms
- capecitabine (en)
- Capécitabine (fr)
Safety and technical documents
General references and manufacturer-specific SDS documents are kept separate.
No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.
End-to-end traceability
Only links supported by an identified source are published. Missing evidence remains explicitly unknown.
Evidence still missing
- Country or region of origin
- Raw-material producer
- Ingredient manufacturer
- Distributor
- Transformation steps
Documented origins
No origin has been proven yet by an explicit source.
Documented organizations
No organization has been proven yet by an explicit source.
Documented transformations
No transformation step has been proven yet by an explicit source.
Method: a company’s registration country is never used as evidence of a material’s origin.
Products containing this ingredient
ACH-CAPECITABINE
150 · MG
ACH-CAPECITABINE
500 · MG
APO-CAPECITABINE
150 · MG
APO-CAPECITABINE
500 · MG
CAPECITABINE
150 · MG
CAPECITABINE
500 · MG
CAPECITABINE
150 · MG
CAPECITABINE
500 · MG
CAPECITABINE
150 · MG
CAPECITABINE
500 · MG
MINT-CAPECITABINE
150 · MG
MINT-CAPECITABINE
500 · MG
SANDOZ CAPECITABINE
150 · MG
SANDOZ CAPECITABINE
500 · MG
TARO-CAPECITABINE
150 · MG
TARO-CAPECITABINE
500 · MG
TEVA-CAPECITABINE
150 · MG
TEVA-CAPECITABINE
500 · MG
XELODA
150 · MG
XELODA
500 · MG